KemPharm - 4 Year Stock Price History | KMPH

Historical daily share price chart and data for KemPharm since 2015 adjusted for splits. The latest closing stock price for KemPharm as of April 18, 2019 is 1.62.
  • The all-time high KemPharm stock price is 23.63, which is 1358.6% above the current share price.
  • The KemPharm 52-week high stock price is 6.95, which is 329% above the current share price.
  • The KemPharm 52-week low stock price is 1.62, which is 0% below the current share price.
  • The average KemPharm stock price for the last 52 weeks is 3.70.
KemPharm Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.1918 1.9800 2.8000 1.6200 1.6200 -8.99%
2018 4.8843 4.1500 8.0000 1.7500 1.7800 -56.05%
2017 3.7529 3.2500 5.0000 2.5500 4.0500 37.29%
2016 8.3848 18.4300 18.6800 2.9500 2.9500 -85.15%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.044B $0.000B
KemPharm Inc. is a specialty pharmaceutical company which is engaged in the discovery and development of new molecular entity prodrugs. Its product candidates include KP201/APAP, KP511/ER and KP606/ER for the treatment of pain; KP415 for the treatment of attention deficit hyperactivity disorder and KP303 for the treatment of central nervous system disorders, which are in preclinical trail stage. The Company through its LAT platform technology generate prodrug. KemPharm Inc. is based in CORALVILLE, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.954B 31.20
Takeda Pharmaceutical (TAK) Japan $28.872B 10.68
Grifols (GRFS) Spain $12.960B 15.84
Ionis Pharmaceuticals (IONS) United States $10.057B 31.19
Sage Therapeutics (SAGE) United States $7.604B 0.00
Neurocrine Biosciences (NBIX) United States $7.369B 477.29
Jazz Pharmaceuticals (JAZZ) Ireland $7.285B 10.43
Catalent (CTLT) United States $6.226B 26.07
Nektar Therapeutics (NKTR) United States $5.430B 8.66
Tilray (TLRY) United States $4.722B 0.00
United Therapeutics (UTHR) United States $4.401B 7.48
Taro Pharmaceutical Industries (TARO) Israel $4.054B 13.05
FibroGen (FGEN) United States $3.948B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.737B 0.00
Portola Pharmaceuticals (PTLA) United States $2.206B 0.00
PTC Therapeutics (PTCT) United States $2.060B 0.00
USANA Health Sciences (USNA) United States $1.943B 16.31
Aerie Pharmaceuticals (AERI) United States $1.827B 0.00
Heron Therapeutics (HRTX) United States $1.776B 0.00
Xencor (XNCR) United States $1.748B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.732B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.721B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.655B 20.61
Madrigal Pharmaceuticals (MDGL) United States $1.638B 0.00
Endo (ENDP) Ireland $1.604B 2.47
Zogenix (ZGNX) United States $1.547B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.508B 130.61
Corcept Therapeutics (CORT) United States $1.369B 19.88
Tricida (TCDA) United States $1.345B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.264B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.076B 0.00
Esperion Therapeutics (ESPR) United States $1.076B 0.00
Radius Health (RDUS) United States $1.016B 0.00
TherapeuticsMD (TXMD) United States $1.013B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.847B 0.00
Akebia Therapeutics (AKBA) United States $0.810B 0.00
CannTrust Holdings (CTST) Canada $0.768B 0.00
ChemoCentryx (CCXI) United States $0.709B 0.00
ArQule (ARQL) United States $0.692B 0.00
Odonate Therapeutics (ODT) United States $0.597B 0.00
Dermira (DERM) United States $0.597B 0.00
Forty Seven (FTSV) United States $0.588B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.578B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.561B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.540B 0.00
GlycoMimetics (GLYC) United States $0.517B 0.00
Translate Bio (TBIO) United States $0.468B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.464B 23.97
Collegium Pharmaceutical (COLL) United States $0.454B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.447B 0.00
KalVista Pharmaceuticals (KALV) United States $0.438B 0.00
Siga Technologies (SIGA) United States $0.425B 0.00
OptiNose (OPTN) United States $0.421B 0.00
TCR2 THERAPTCS (TCRR) United States $0.417B 0.00
Aptorum Group (APM) China $0.392B 0.00
Flexion Therapeutics (FLXN) United States $0.389B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.388B 0.00
ImmunoGen (IMGN) United States $0.378B 0.00
Mast Therapeutics (SVRA) United States $0.323B 0.00
CASI Pharmaceuticals (CASI) United States $0.320B 0.00
Harpoon Therapy (HARP) United States $0.307B 0.00
Karyopharm Therapeutics (KPTI) United States $0.293B 0.00
Minerva Neurosciences (NERV) United States $0.279B 0.00
Lannett Co Inc (LCI) United States $0.276B 2.57
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.274B 10.14
Verrica Pharmaceuticals (VRCA) United States $0.272B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.265B 0.00
Xeris Pharmaceuticals (XERS) United States $0.255B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.248B 0.00
Calithera Biosciences (CALA) United States $0.239B 0.00
Dova Pharmaceuticals (DOVA) United States $0.235B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
Opexa Therapeutics (ACER) United States $0.229B 0.00
Molecular Templates (MTEM) United States $0.224B 0.00
Ardelyx (ARDX) United States $0.217B 0.00
Affimed (AFMD) Germany $0.215B 0.00
Aclaris Therapeutics (ACRS) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.211B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.209B 0.00
Aldeyra Therapeutics (ALDX) United States $0.202B 0.00
Rafael Holdings (RFL) United States $0.200B 0.00
Galectin Therapeutics (GALT) United States $0.200B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.194B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.189B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.186B 0.00
Jounce Therapeutics (JNCE) United States $0.185B 0.00
Recro Pharma (REPH) United States $0.181B 0.00
IMV INC (IMV) Canada $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 186.20
Majesco Entertainment (PTE) United States $0.177B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
Redhill Biopharma (RDHL) Israel $0.174B 0.00
Aratana Therapeutics (PETX) United States $0.173B 0.00
Tyme Technologies (TYME) United States $0.168B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.168B 0.00
AgeX Therapeutics (AGE) United States $0.168B 0.00
ElectroCore (ECOR) United States $0.164B 0.00
Ocular Therapeutix (OCUL) United States $0.156B 0.00
Aquestive Therapeutics (AQST) United States $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.147B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.142B 0.00
China SXT Pharmaceuticals (SXTC) China $0.124B 0.00
MediWound (MDWD) Israel $0.121B 0.00
Iterum Therapeutics (ITRM) Ireland $0.119B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
ProNAi Therapeutics (SRRA) Canada $0.107B 0.00
Nivalis Therapeutics (ALPN) United States $0.101B 0.00
Neos Therapeutics (NEOS) United States $0.100B 0.00
Zafgen (ZFGN) United States $0.100B 0.00
Natural Alternatives (NAII) United States $0.097B 9.49
Oasmia Pharmaceutical AB (OASM) Sweden $0.097B 0.00
DURECT (DRRX) United States $0.094B 0.00
Adherex Technologies (FENC) United States $0.094B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.090B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.088B 0.00
Champions Oncology (CSBR) United States $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
SCYNEXIS (SCYX) United States $0.081B 0.00
Otonomy (OTIC) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.077B 0.00
Avenue Therapeutics (ATXI) United States $0.073B 0.00
India Globalization Capital (IGC) United States $0.067B 0.00
Capnia (SLNO) United States $0.063B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.054B 0.00
Bio-Path Holdings (BPTH) United States $0.051B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Melinta Therapeutics (MLNT) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
ContraFect (CFRX) United States $0.047B 0.00
Lipocine (LPCN) United States $0.046B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.043B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.039B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.032B 0.00
Shineco (TYHT) China $0.028B 4.65
Summit Therapeutics (SMMT) United Kingdom $0.027B 3.53
IsoRay (ISR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
NOVAN INC (NOVN) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.83
Achaogen (AKAO) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.008B 0.00
VAXART, INC (VXRT) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00